{
    "pmcid": "8564274",
    "qa_pairs": {
        "How does the bivalent form n3113.1-Fc enhance its neutralization capacity?": [
            "By fusing n3113.1 to the Fc domain of human IgG1, increasing avidity effects.",
            "By directly blocking the ACE2 receptor binding site on the spike protein.",
            "By binding to both the S1 and S2 subunits of the spike protein simultaneously.",
            "By incorporating additional mutations to increase its binding affinity to the RBD."
        ],
        "What is the unique binding characteristic of the single-domain antibody n3113 described in the study?": [
            "n3113 binds to a novel epitope on the side surface of the 'up' state RBD without competing with the ACE2 receptor.",
            "n3113 competes directly with the ACE2 receptor for binding to the RBD.",
            "n3113 binds to the 'down' state RBD, preventing ACE2 receptor interaction.",
            "n3113 targets the S2 subunit of the spike protein, inhibiting membrane fusion."
        ],
        "What potential advantage does the small size and non-ACE2 competing nature of n3113.1-Fc offer for therapeutic application?": [
            "It could be administered via inhalation, offering direct delivery to the respiratory tract.",
            "It allows for oral administration, enhancing patient compliance.",
            "It enables the antibody to be delivered through intravenous injection only.",
            "It provides a longer half-life in the bloodstream compared to larger antibodies."
        ],
        "What structural feature of the SARS-CoV-2 spike protein is targeted by the n3113 antibody?": [
            "The side surface of the 'up' state RBD.",
            "The N-terminal domain of the S1 subunit.",
            "The fusion peptide region of the S2 subunit.",
            "The central helix of the trimeric spike protein."
        ],
        "Which mutation in n3113.1-Fc restored its neutralization capacity against the Delta variant?": [
            "Y58L mutation.",
            "L452R mutation.",
            "N165G mutation.",
            "D614G mutation."
        ]
    }
}